[Botulinum toxin versus sacral neuromodulation for idiopathic detrusor overactivity]

Area of Science:

• Urology
• Neuroscience
• Pharmacology

Background:

• Idiopathic detrusor overactivity significantly impacts patient quality of life.
• Conservative treatments for detrusor overactivity often lack efficacy and cause side effects.
• Sacral neuromodulation is a recognized second-line therapy for refractory overactive bladder.

Purpose of the Study:

• To compare the efficacy, safety, and cost-effectiveness of sacral neuromodulation versus botulinum toxin injections for idiopathic detrusor overactivity.
• To evaluate emerging evidence on botulinum toxin as an alternative treatment for overactive bladder.
• To provide a comprehensive review for clinical decision-making in overactive bladder management.

Main Methods:

• Systematic review of randomized controlled trials and comparative studies.
• Analysis of efficacy parameters including incontinence episodes, voiding frequency, and quality of life scores.
• Assessment of safety profiles, adverse events, and cost-effectiveness data.

Main Results:

• Both sacral neuromodulation and botulinum toxin injections demonstrate significant improvements in overactive bladder symptoms compared to placebo or conservative management.
• Botulinum toxin injections may offer a less invasive initial approach with comparable efficacy in the short term.
• Long-term data on sacral neuromodulation suggests sustained efficacy, while botulinum toxin requires repeat injections.

Conclusions:

• Sacral neuromodulation and botulinum toxin injections are effective treatment options for idiopathic detrusor overactivity.
• The choice between treatments depends on patient factors, including invasiveness, duration of effect, and cost.
• Further high-quality, long-term comparative studies are needed to fully elucidate the optimal treatment pathway.